Absence of transforming growth factor-β type II receptor is associated with poorer prognosis in HER2-negative breast tumours

Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinoma

(2009) Fabíola E Rosa et al.   BMC CANCER

Transforming growth factor-β signaling: emerging stem cell target in metastatic breast cancer?

(2008) Antoinette R. Tan et al.   BREAST CANCER RESEARCH AND TREATMENT

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

(2008) Li Yang et al.   CANCER CELL

TGFβ in Cancer

(2008) Joan Massagué   CELL

Advances in Breast Cancer: Pathways to Personalized Medicine

(2008) O. I. Olopade et al.   CLINICAL CANCER RESEARCH

Triple-Negative Breast Cancer: Risk Factors to Potential Targets

(2008) B. P. Schneider et al.   CLINICAL CANCER RESEARCH

Evaluation of estrogen receptor α and β and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers

(2008) Fabíola E. Rosa et al.   HUMAN PATHOLOGY